About
Obesity Therapies, Peptides, Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalGene Therapy, RNA & Peptide TherapyAntibodyNJ, NY, PA
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
1,114
By Phase
PHASE2: 3PHASE1: 1PHASE1/PHASE2: 2
By Status
ACTIVE_NOT_RECRUITING: 3RECRUITING: 3
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06973720Lead Sponsor
A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight
PHASE2Active, not recruiting
250 participants
Started: Apr 1, 2025 · Completed: Oct 31, 2026
NCT06897202Lead Sponsor
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM
PHASE2Recruiting
125 participants
Started: Mar 14, 2025 · Completed: Jun 30, 2026
NCT06924320Lead Sponsor
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
PHASE1Recruiting
132 participants
Started: Mar 3, 2025 · Completed: Jan 31, 2026
NCT07022977Lead Sponsor
A Study of MET233 in Individuals With Obesity or Overweight
PHASE1/PHASE2Recruiting
120 participants
Started: Nov 20, 2024 · Completed: Jan 3, 2026
NCT06712836Lead Sponsor
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight
PHASE2Active, not recruiting
225 participants
Started: Oct 24, 2024 · Completed: May 31, 2026
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...